Product Information
OLMESARTAN-HYDROCHLOROTHIAZIDE 40-25 MG TAB is a generic product labeled by Alembic Pharmaceuticals Inc., priced at $0.2214 per EA under NDC 62332015130. Its NADAC has been published 481 times since Jun 7, 2017.
FDA first approved this application on Apr 24, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
OLMESARTAN-HYDROCHLOROTHIAZIDE 40-25 MG TAB
Olmesartan Medoxomil and HydrochlorothiazideStrength
25; 40 mg/1; mg/1
Manufacturer
Alembic Pharmaceuticals Inc.NDC
62332015130
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMILApproval Type
Generic (ANDA)
FDA Application
ANDA204233FDA Approved
4/24/2017
TE Code
AB
On Market Since
4/24/2017
Pharmacological Classes
Price Statistics
The NADAC for OLMESARTAN-HYDROCHLOROTHIAZIDE 40-25 MG TAB has been published 481 times since Jun 7, 2017, and over the history we have for it it has declined 96.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2214 per EA |
|---|---|
| All-time high | $5.6051 (Jun 14, 2017) |
| All-time low | $0.1789 (Nov 20, 2024) |
| 52-week high | $0.2343 |
| 52-week low | $0.2023 |
| Median price | $0.2642 |
| Average price | $0.3375 |
| Largest weekly change | -92.6% (Jul 19, 2017) |
| Weeks tracked | 481 |
| Tracking since | Jun 7, 2017 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of OLMESARTAN-HYDROCHLOROTHIAZIDE 40-25 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for OLMESARTAN-HYDROCHLOROTHIAZIDE 40-25 MG TAB, manufactured by Alembic Pharmaceuticals Inc., is $0.2214 per EA (NDC 62332015130), effective Aug 19, 2026.
How has the price of OLMESARTAN-HYDROCHLOROTHIAZIDE 40-25 MG TAB changed over time?
Over the history we have for it, the NADAC for OLMESARTAN-HYDROCHLOROTHIAZIDE 40-25 MG TAB has declined 96.1%. It has been tracked across 481 weekly CMS publications since Jun 7, 2017.
What are the highest and lowest recorded NADAC prices for OLMESARTAN-HYDROCHLOROTHIAZIDE 40-25 MG TAB?
Since Jun 7, 2017, the NADAC for OLMESARTAN-HYDROCHLOROTHIAZIDE 40-25 MG TAB has ranged from a low of $0.1789 (Nov 20, 2024) to a high of $5.6051 (Jun 14, 2017), with a median of $0.2642 per EA.
Are there cheaper alternatives to OLMESARTAN-HYDROCHLOROTHIAZIDE 40-25 MG TAB?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as OLMESARTAN-HYDROCHLOROTHIAZIDE 40-25 MG TAB in a comparable dosage form, but none are currently priced below it.
Who manufactures OLMESARTAN-HYDROCHLOROTHIAZIDE 40-25 MG TAB?
OLMESARTAN-HYDROCHLOROTHIAZIDE 40-25 MG TAB (NDC 62332015130) is labeled by Alembic Pharmaceuticals Inc., and CMS classifies it as a generic product.